119 related articles for article (PubMed ID: 17174330)
1. Serpin acceleration of amyloid fibril formation: a role for accessory proteins.
Powers GA; Pham CL; Pearce MC; Howlett GJ; Bottomley SP
J Mol Biol; 2007 Feb; 366(2):666-76. PubMed ID: 17174330
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining.
Binger KJ; Pham CL; Wilson LM; Bailey MF; Lawrence LJ; Schuck P; Howlett GJ
J Mol Biol; 2008 Feb; 376(4):1116-29. PubMed ID: 18206908
[TBL] [Abstract][Full Text] [Related]
4. Shear flow induced changes in apolipoprotein C-II conformation and amyloid fibril formation.
Teoh CL; Bekard IB; Asimakis P; Griffin MD; Ryan TM; Dunstan DE; Howlett GJ
Biochemistry; 2011 May; 50(19):4046-57. PubMed ID: 21476595
[TBL] [Abstract][Full Text] [Related]
5. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ
Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947
[TBL] [Abstract][Full Text] [Related]
6. Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils.
Binger KJ; Griffin MD; Howlett GJ
Biochemistry; 2008 Sep; 47(38):10208-17. PubMed ID: 18729385
[TBL] [Abstract][Full Text] [Related]
7. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
Hung A; Griffin MD; Howlett GJ; Yarovsky I
J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
[TBL] [Abstract][Full Text] [Related]
8. Is the binding of beta-amyloid protein to antichymotrypsin in Alzheimer plaques mediated by a beta-strand insertion?
Lukacs CM; Christianson DW
Proteins; 1996 Aug; 25(4):420-4. PubMed ID: 8865337
[TBL] [Abstract][Full Text] [Related]
9. Interpreting the aggregation kinetics of amyloid peptides.
Pellarin R; Caflisch A
J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
[TBL] [Abstract][Full Text] [Related]
10. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
[TBL] [Abstract][Full Text] [Related]
11. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of fibril formation of bovine kappa-casein indicate a conformational rearrangement as a critical step in the process.
Leonil J; Henry G; Jouanneau D; Delage MM; Forge V; Putaux JL
J Mol Biol; 2008 Sep; 381(5):1267-80. PubMed ID: 18616951
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol binding to amyloid-beta fibrils: a TEM study.
Harris JR
Micron; 2008 Dec; 39(8):1192-6. PubMed ID: 18586500
[TBL] [Abstract][Full Text] [Related]
14. Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils.
Binger KJ; Ecroyd H; Yang S; Carver JA; Howlett GJ; Griffin MD
FASEB J; 2013 Mar; 27(3):1214-22. PubMed ID: 23159935
[TBL] [Abstract][Full Text] [Related]
15. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.
Giunta S; Galeazzi R; Marcellini M; Corder EH; Galeazzi L
Clin Biochem; 2007 Aug; 40(12):887-92. PubMed ID: 17512513
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of a fibrillogenic peptide derived from apolipoprotein C-II.
Legge FS; Treutlein H; Howlett GJ; Yarovsky I
Biophys Chem; 2007 Nov; 130(3):102-13. PubMed ID: 17825978
[TBL] [Abstract][Full Text] [Related]
17. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.
Rocha S; Thünemann AF; Pereira Mdo C; Coelho M; Möhwald H; Brezesinski G
Biophys Chem; 2008 Sep; 137(1):35-42. PubMed ID: 18625543
[TBL] [Abstract][Full Text] [Related]
18. Amyloid fibril formation by human stefin B in vitro: immunogold labelling and comparison to stefin A.
Zerovnik E; Zavasnik-Bergant V; Kopitar-Jerala N; Pompe-Novak M; Skarabot M; Goldie K; Ravnikar M; Musevic I; Turk V
Biol Chem; 2002 May; 383(5):859-63. PubMed ID: 12108553
[TBL] [Abstract][Full Text] [Related]
19. Abeta-globulomers are formed independently of the fibril pathway.
Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
[TBL] [Abstract][Full Text] [Related]
20. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
